Located within the Monash Technology Precinct, at the corner of Blackburn and Wellington roads, the facility will join a host of world-leading research and technology facilities already established in the precinct, including CSIRO, Australian Synchrotron, Victorian Heart Hospital, and Melbourne Centre for ...
Both of the mRNA vaccines available in the US are highly effective against severe COVID-19, but recent studies suggest that Moderna's elicits a stronger immune response and might be better at preventing breakthrough infections.
Moderna uses the same mRNA technology as Pfizer-BioNTech and had a similarly high efficacy at preventing symptomatic disease when the companies applied for authorization; it also needs to be stored in freezer-level temperatures.
Now, a new study has flagged higher risks of heart inflammation associated with Moderna's shot compared with the rival from Pfizer and BioNTech.
How many doses for Moderna? And how far apart? Despite their similarities, the Moderna doses have more than three times the amount of mRNA material (100 micrograms), compared to Pfizer (30 micrograms). The dose spacing is also different: three weeks apart for Pfizer and four weeks for Moderna.
NEW YORK and MAINZ, GERMANY, March 14, 2023 —Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) to provide a single booster dose of the companies' Omicron BA. 4/BA.
The rate of positive tests after 20 weeks was 164 per 1,000 people for those who had Pfizer and 160 for Moderna. This means that there were around 4 fewer (95% confidence interval is 3.0 to 5.5) positive tests per 1,000 people for Moderna than for Pfizer after 20 weeks.
Moderna vaccine can be stored at frozen temperatures (-25° to -15°C) for up to 6 months. Refrigerated storage Moderna vaccine can be stored at refrigerator temperatures (2° to 8°C) for up to 30 days. Room temperature Moderna vaccine can be stored at 15° to 25°C (59° to 77°F) for 12 hours. min before use.
'Australia's science and R&D ecosystem is world-class, and this is one of the reasons we decided to build our first commercial-scale facility in Australia,' says Michael Azrak, General Manager, Moderna Australia & New Zealand.
As a result, the EUAs of the original monovalent mRNA vaccines developed by Pfizer/BioNTech and Moderna for the prevention of Covid-19 have been revoked, meaning they are no longer authorised for use in the US.
Moderna yanked the shots because of a “foreign body” found in one vial of the batch made at Rovi's site in Spain, the partners said in a release. The suspect vial was punctured but not administered, the companies added. Moderna and Rovi learned about the contamination issue from a vaccination center in Málaga, Spain.
Besides CMOs, Moderna also manufactures the vaccine at its own production facility in Norwood, Massachusetts. Another manufacturing site for the vaccines for the market outside the U.S. (since the end of 2021) is in Geleen in the Netherlands, produced by its manufacturing partner Lonza.
Approval for use in Australia
Moderna is approved and available for use as a booster in people aged 18 years and over. The Therapeutic Good Administration (TGA) provisionally approved it for use in Australia on: 9 August 2021 (primary course - for 18 years and over)
Moderna's name combines the words "modified" and "RNA", which happens to contain the word "modern.”
In December 2018, Moderna became a public company via the largest initial public offering of a biotechnology company in history, raising $621 million by selling 27 million shares at $23 per share.
The Australian Government has entered into a ten-year partnership with Moderna and the Victorian Government that will see Moderna build an mRNA vaccine manufacturing facility at Monash University Victoria.
COVID-19 Vaccine Moderna received a conditional marketing authorisation valid throughout the EU on 6 January 2021. This was switched to a standard marketing authorisation on 3 October 2022. The name of the vaccine was changed to Spikevax on 22 June 2021.
Moderna's IPO always looked like a record breaker for biotech and came in even larger than expected at $604 million, valuing the company at an eye-watering $7.9 billion.
How many doses for Moderna? And how far apart? Despite their similarities, the Moderna doses have more than three times the amount of mRNA material (100 micrograms), compared to Pfizer (30 micrograms). The dose spacing is also different: three weeks apart for Pfizer and four weeks for Moderna.
Regulatory approval of Spikevax (formerly COVID-19 Vaccine Moderna) - GOV.UK.
Should you be buying Moderna stock or one of its competitors? The main competitors of Moderna include Biogen (BIIB), Seagen (SGEN), argenx (ARGX), BioNTech (BNTX), Bio-Techne (TECH), Gilead Sciences (GILD), Amgen (AMGN), IDEXX Laboratories (IDXX), Takeda Pharmaceutical (TAK), and DexCom (DXCM).
Now, a new study has flagged higher risks of heart inflammation associated with Moderna's shot compared with the rival from Pfizer and BioNTech.
ATAGI's latest recommendation is particularly important for those aged 65 and over. As Australia prepares to enter its fourth year of tackling COVID-19, the Federal Government has announced an update to the strategy, with adults eligible to receive a fifth vaccination later this month.